Lv5
806 积分 2026-01-25 加入
BYL719, a new α-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma
2个月前
已完结
Dissecting the Interaction Fingerprints and Binding Affinity of BYL719 Analogs Targeting PI3Kα
2个月前
已完结
BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
2个月前
已完结
The Phosphoinositide 3-Kinase Pathway
3个月前
已完结
Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy
3个月前
已完结
Design, synthesis and docking studies of novel thienopyrimidine derivatives bearing chromone moiety as mTOR/PI3Kα inhibitors
3个月前
已完结
Molecular glues that facilitate RAS binding to PI3Kα promote glucose uptake without insulin
3个月前
已完结
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)
3个月前
已完结
Development of PI3Kα inhibitors for tumor therapy
3个月前
已完结
皖公网安备34019202002308
